Health Bulletin 20/February/2023 Dr. Nandita Mohan20 Feb 2023 4:02 PM ISTHere are the top health stories for the day:NCDRC upholds Rs 10 lakh compensation to patient whose fingers got amputated due to gangreneOpining that...
MSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets Dr. Divya Colin19 Feb 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
MSN Labs Gets CDSCO Panel Nod To Manufacture, Market Fesoterodine Fumarate ER tablets Dr. Divya Colin4 Jan 2023 6:00 PM ISTNew Delhi: In response to the Phase III clinical trial report of Fesoterodine Fumarate extended release tablets 4 mg and 8 mg, the Subject Expert...
MSN Laboratories gets CDSCO panel nod to manufacture, market Icatibant Injection Dr. Divya Colin18 Nov 2022 6:00 PM ISTNew Delhi: Directing that the drug should be sold by retail under the prescription of the designated medical specialist only, the Subject Expert...
CDSCO Panel Tells MSN Lab to Produce Raw Data on Icatibant Injection Dr. Divya Colin24 Oct 2022 1:15 PM ISTNew Delhi: In response to drug maker MSN Laboratories' justification for bioavailability (BE) study waiver for Icatibant Injection 30mg/3ml (10mg/ml)...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Ruchika Sharma25 Aug 2022 5:00 PM ISTNew Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Ahead of Linagliptin going off-patent, NPPA fixes retail price of its FDC with Metformin Susmita Roy20 April 2022 6:57 PM ISTNew Delhi: With the popular antidiabetic drug Linagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
NPPA fixes retail prices of 15 formulations, ceiling price of Framycetin Ruchika Sharma19 April 2022 4:06 PM ISTNew Delhi: National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 15...
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 5:44 PM ISTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
MSN Labs gets USFDA nod for generic version of Cangrelor in India Ruchika Sharma17 Dec 2021 1:02 PM ISTHyderabad: Close on the heels of securing Drug Controller General of India's approval for CANREAL injection (generic version of Cangrelor) in India,...
Health Bulletin 25/October/2021 Roshni Dhar25 Oct 2021 4:23 PM ISTHere are Top Health Stories of the dayDoctors cannot function under threat of being harassed, beaten up: High CourtThe Punjab and Haryana High Court...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
